GlassScriptPhysician profile
Gregory B Hoang
NPI 1952362816
$34,804.23
in general payments reported to CMS, 2019-2025
94 companies · $4,184 in 2025
The $4,184 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,715 · 2020: $2,656 · 2021: $6,324 · 2022: $6,752 · 2023: $5,937 · 2024: $6,236 · 2025: $4,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Education: $496 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,694.74 |
| Education | $496.01 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,333.87 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,305.36 | 2019-2025 | Enhertu, Tagrisso, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $1,978.27 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $1,852.85 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $1,834.86 | 2019-2025 | |
| Janssen Biotech, INC. | $1,570.53 | 2019-2025 | Rybrevant, Darzalex, Erleada |
| Amgen INC. | $1,493.02 | 2019-2024 | Kyprolis, Lumakras, Xgeva |
| Incyte Corporation | $1,366.66 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Seagen INC. | $1,246.06 | 2019-2025 | Adcetris, Padcev |
| Astellas Pharma US INC | $1,241.72 | 2019-2025 | Vyloy, Xtandi, Padcev |
| Celgene Corporation | $1,227.71 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Genzyme Corporation | $1,025.07 | 2019-2025 | |
| Genentech USA, INC. | $1,018.65 | 2019-2025 | Lunsumio, Tecentriq, Polivy |
| Daiichi Sankyo INC. | $854.85 | 2019-2025 | Enhertu, Datroway, Vanflyta |
| Lilly USA, LLC | $770.74 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
Show all 94 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $697.03 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Eisai INC. | $608.59 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $590.89 | 2019-2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $571.28 | 2019-2025 | Fruzaqla, Iclusig, Ninlaro |
| Abbvie INC. | $494.26 | 2019-2025 | |
| Kite Pharma, INC. | $486.53 | 2021-2025 | Yescarta |
| Gilead Sciences, INC. | $456.48 | 2021-2025 | Trodelvy |
| Pharmacyclics LLC, An Abbvie Company | $438.86 | 2019-2023 | Imbruvica, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $432.92 | 2019-2025 | |
| Exelixis INC. | $354.06 | 2020-2025 | Cabometyx |
| Ipsen Biopharmaceuticals, INC | $333.98 | 2019-2025 | Onivyde, Somatuline Depot |
| Jazz Pharmaceuticals INC. | $331.49 | 2021-2025 | |
| Pharmacosmos Therapeutics INC. | $315.47 | 2020-2025 | Monoferric, Cosela |
| Karyopharm Therapeutics INC. | $302.20 | 2020-2025 | Xpovio |
| Alexion Pharmaceuticals, INC. | $296.91 | 2020-2025 | Ultomiris |
| Array Biopharma INC | $292.49 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Sobi, INC | $255.14 | 2022-2025 | |
| Beigene USA, INC. | $240.73 | 2022-2024 | Brukinsa |
| Taiho Oncology, INC. | $227.28 | 2019-2024 | |
| Mirati Therapeutics, INC. | $223.90 | 2023-2024 | Krazati |
| Adc Therapeutics America, INC. | $206.27 | 2022-2025 | |
| Emd Serono, INC. | $195.59 | 2019-2025 | Tepmetko, Bavencio |
| Novocure INC. | $171.92 | 2023-2024 | Optune, Optune Lua (Novottf-200t) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.05 | 2020-2022 | |
| Servier Pharmaceuticals LLC | $155.00 | 2021-2025 | |
| Aveo Pharmaceuticals, INC. | $146.56 | 2022-2025 | |
| Morphosys, US INC. | $140.01 | 2021-2022 | |
| Pharmaessentia USA Corporation | $133.15 | 2022-2025 | Besremi |
| Kyowa Kirin, INC. | $128.60 | 2019-2023 | Poteligeo |
| Sumitomo Pharma America, INC. | $116.24 | 2023-2025 | Orgovyx |
| Sanofi-Aventis U.S. LLC | $99.99 | 2023 | |
| Stemline Therapeutics INC. | $99.44 | 2023-2025 | Orserdu |
| Puma Biotechnology, INC. | $99.43 | 2019-2025 | |
| Agios Pharmaceuticals, INC. | $92.59 | 2023-2025 | Pyrukynd |
| Beone Medicines USA, INC. | $90.94 | 2025 | Brukinsa |
| Rigel Pharmaceuticals, INC. | $90.03 | 2019-2023 | Rezlidhia, Tavalisse |
| Global Blood Therapeutics, INC. | $84.78 | 2020-2022 | |
| G1 Therapeutics, INC. | $82.96 | 2022-2023 | Cosela |
| Tersera Therapeutics LLC | $81.05 | 2023-2025 | Zoladex |
| Deciphera Pharmaceuticals INC. | $75.47 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Caris Mpi, INC. | $74.32 | 2025 | Mi Cancer Seek |
| Blueprint Medicines Corporation | $71.17 | 2023-2025 | Ayvakit |
| Clovis Oncology, INC. | $64.58 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $61.34 | 2022-2024 | Givlaari |
| Dendreon Pharmaceuticals LLC | $61.11 | 2024-2025 | Provenge |
| Springworks Therapeutics, INC. | $58.72 | 2024-2025 | Ogsiveo |
| Myovant Sciences INC. | $53.48 | 2021-2022 | |
| Epizyme, INC. | $51.06 | 2020-2022 | |
| Dova Pharmaceuticals | $48.02 | 2021 | |
| Mylan Institutional INC. | $46.90 | 2021-2023 | Fulphila, Ogivri |
| Verity Pharmaceuticals INC. | $45.12 | 2023-2025 | Trelstar |
| Eusa Pharma (US) LLC | $37.87 | 2021-2022 | |
| Heron Therapeutics, INC. | $37.36 | 2019-2022 | |
| Fennec Pharmaceuticals, INC. | $34.69 | 2025 | Fyarro |
| Tesaro, INC. | $31.66 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.07 | 2019-2021 | |
| Legend Biotech USA INC. | $28.99 | 2024 | |
| Genmab U.S., INC. | $28.55 | 2024 | Epkinly |
| Acceleron Pharma, INC. | $27.53 | 2021 | |
| Amag Pharmaceuticals, INC. | $25.81 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $24.83 | 2023 | Empaveli |
| Fortovia Therapeutics, INC. | $24.52 | 2020 | |
| Geron Corporation | $24.40 | 2025 | Rytelo |
| Sun Pharmaceutical Industries INC. | $24.25 | 2022 | |
| Tg Therapeutics, INC. | $24.11 | 2021 | |
| Corcept Therapeutics | $23.58 | 2025 | Korlym |
| Adaptive Biotechnologies Corporation | $22.03 | 2025 | Clonoseq |
| Accord Healthcare, INC. | $20.28 | 2023 | |
| Emmaus Medical, INC. | $19.66 | 2020 | |
| Amneal Pharmaceuticals LLC | $19.06 | 2025 | Alymsys |
| Tempus Ai, INC | $18.87 | 2025 | Xt Cdx |
| Digestive Care, INC. | $18.58 | 2025 | Pertzye |
| Cti Biopharma Corp. | $18.16 | 2023 | Vonjo |
| Advanced Accelerator Applications | $17.92 | 2019 | |
| Syndax Pharmaceuticals, INC. | $17.64 | 2025 | |
| Verastem, INC. | $14.55 | 2019 | |
| Octapharma USA, INC. | $14.25 | 2019 | |
| Sirtex Medical INC | $11.10 | 2020 | |
| Organon LLC | $10.31 | 2022 |
Drugs and devices associated with these payments
Keytruda $993Enhertu $708Opdivo $559Lynparza $515Verzenio $394Adcetris $378Xtandi $371Rybrevant $332Orgovyx $311Kisqali $310Imbruvica $305Brukinsa $301Trodelvy $298Ojjaara $296Reblozyl $290Lorbrena $279Venclexta $271Jaypirca $270Tagrisso $266Jakafi $264Libtayo $250Welireg $248Kyprolis $248Krazati $224Padcev $221Braftovi $213Vyloy $208Pluvicto $206Monoferric $199Xpovio $196Elrexfio $193Mektovi $192Tukysa $190Enjaymo $190Talzenna $189Lunsumio $186Ibrance $186Fruzaqla $185Vonjo $183Lenvima $180Imfinzi $176Jemperli $174Pomalyst $165Sarclisa $163Yescarta $160Nubeqa $159Optune $158Inlyta $153Ultomiris $151Retevmo $147Epkinly $144Lonsurf $140Bosulif $139Cabometyx $138Comirnaty $137Scemblix $127Paxlovid $122Piqray $120Darzalex $120Besremi $109Erleada $102Elitek $99.99Orserdu $99.44Zejula $98.31Monjuvi $96.30Ayvakit $95.04Stivarga $94.53Vitrakvi $94.53Tibsovo $86.21Onivyde $82.81Zoladex $81.05Pyrukynd $77.22Mi Cancer Seek $74.32Pertzye $74.32Tasigna $74.07Tecentriq $72.71Zepzelca $70.40Tivdak $68.52Besponsa $63.21Polivy $61.74Provenge $61.11Iclusig $60.69Lumakras $60.45Talvey $59.68Balversa $59.32Tecvayli $59.24Ogsiveo $58.72Cosela $58.09Fabhalta $57.07Bavencio $56.75Jevtana $53.56Lutathera $51.12Zynyz $50.94Elahere $50.32Keytruda Qlex $50.25Doptelet $49.73Xospata $48.37Ninlaro $46.16Promacta $46.16Qinlock $45.76
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.